{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:54:58Z","timestamp":1762458898417},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bone"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.bone.2011.06.008","type":"journal-article","created":{"date-parts":[[2011,6,26]],"date-time":"2011-06-26T00:28:32Z","timestamp":1309048112000},"page":"653-661","source":"Crossref","is-referenced-by-count":11,"title":["The Sox2 high mobility group transcription factor inhibits mature osteoblast function in transgenic mice"],"prefix":"10.1016","volume":"49","author":[{"given":"Greg","family":"Holmes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy G.","family":"Bromage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Basilico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2011.06.008_bb0005","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1146\/annurev.cellbio.042308.113308","article-title":"Genetic control of bone formation","volume":"25","author":"Karsenty","year":"2009","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1016\/j.bone.2011.06.008_bb0010","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.abb.2008.02.030","article-title":"Transcription factors controlling osteoblastogenesis","volume":"473","author":"Marie","year":"2008","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.bone.2011.06.008_bb0015","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/346245a0","article-title":"A gene mapping to the sex-determining region of the mouse Y chromosome is a member of a novel family of embryonically expressed genes","volume":"346","author":"Gubbay","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.bone.2011.06.008_bb0020","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1101\/gad.224503","article-title":"Multipotent cell lineages in early mouse development depend on SOX2 function","volume":"17","author":"Avilion","year":"2003","journal-title":"Genes Dev"},{"key":"10.1016\/j.bone.2011.06.008_bb0025","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1242\/dev.01204","article-title":"Sox2 deficiency causes neurodegeneration and impaired neurogenesis in the adult mouse brain","volume":"131","author":"Ferri","year":"2004","journal-title":"Development"},{"key":"10.1016\/j.bone.2011.06.008_bb0030","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000082134","article-title":"SOX2, a persistent marker for multipotential neural stem cells derived from embryonic stem cells, the embryo or the adult","volume":"26","author":"Ellis","year":"2004","journal-title":"Dev Neurosci"},{"key":"10.1016\/j.bone.2011.06.008_bb0035","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.biocel.2009.08.018","article-title":"Sox2 roles in neural stem cells","volume":"42","author":"Pevny","year":"2010","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.bone.2011.06.008_bb0040","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/ng1120","article-title":"Mutations in SOX2 cause anophthalmia","volume":"33","author":"Fantes","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.bone.2011.06.008_bb0045","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1083\/jcb.200409182","article-title":"Sox2 induction by FGF and FGFR2 activating mutations inhibits Wnt signaling and osteoblast differentiation","volume":"168","author":"Mansukhani","year":"2005","journal-title":"J Cell Biol"},{"key":"10.1016\/j.bone.2011.06.008_bb0050","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1128\/MCB.01849-07","article-title":"Fibroblast growth factor signaling uses multiple mechanisms to inhibit Wnt-induced transcription in osteoblasts","volume":"28","author":"Ambrosetti","year":"2008","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bone.2011.06.008_bb0055","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/cdd.2010.57","article-title":"The transcription factor Sox2 is required for osteoblast self-renewal","volume":"17","author":"Basu-Roy","year":"2010","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.bone.2011.06.008_bb0060","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1083\/jcb.129.5.1421","article-title":"Separate cis-acting DNA elements of the mouse pro-alpha 1(I) collagen promoter direct expression of reporter genes to different type I collagen-producing cells in transgenic mice","volume":"129","author":"Rossert","year":"1995","journal-title":"J Cell Biol"},{"key":"10.1016\/j.bone.2011.06.008_bb0065","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1101\/gad.9.21.2635","article-title":"Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3","volume":"9","author":"Yuan","year":"1995","journal-title":"Genes Dev"},{"key":"10.1016\/j.bone.2011.06.008_bb0070","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ydbio.2009.01.026","article-title":"Early onset of craniosynostosis in an Apert mouse model reveals critical features of this pathology","volume":"328","author":"Holmes","year":"2009","journal-title":"Dev Biol"},{"key":"10.1016\/j.bone.2011.06.008_bb0075","doi-asserted-by":"crossref","first-page":"8819","DOI":"10.1073\/pnas.83.23.8819","article-title":"Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence","volume":"83","author":"Oldberg","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bone.2011.06.008_bb0080","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1242\/dev.02171","article-title":"The homeoprotein engrailed 1 has pleiotropic functions in calvarial intramembranous bone formation and remodeling","volume":"133","author":"Deckelbaum","year":"2006","journal-title":"Development"},{"key":"10.1016\/j.bone.2011.06.008_bb0085","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bone.2011.06.008_bb0090","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1359\/jbmr.080216","article-title":"Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength","volume":"23","author":"Li","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2011.06.008_bb0095","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/382448a0","article-title":"Increased bone formation in osteocalcin-deficient mice","volume":"382","author":"Ducy","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.bone.2011.06.008_bb0100","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1074\/jbc.M203250200","article-title":"Targeted disruption of the osteoblast\/osteocyte factor 45 gene (OF45) results in increased bone formation and bone mass","volume":"278","author":"Gowen","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2011.06.008_bb0105","doi-asserted-by":"crossref","first-page":"5883","DOI":"10.1242\/dev.01461","article-title":"Altered endochondral bone development in matrix metalloproteinase 13-deficient mice","volume":"131","author":"Stickens","year":"2004","journal-title":"Development"},{"key":"10.1016\/j.bone.2011.06.008_bb0110","first-page":"759","article-title":"Expression of interstitial collagenase during skeletal development of the mouse is restricted to osteoblast-like cells and hypertrophic chondrocytes","volume":"6","author":"Gack","year":"1995","journal-title":"Cell Growth Differ"},{"key":"10.1016\/j.bone.2011.06.008_bb0115","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/(SICI)1097-0177(199703)208:3<387::AID-AJA9>3.0.CO;2-E","article-title":"Collagenase-3 (MMP-13) is expressed by hypertrophic chondrocytes, periosteal cells, and osteoblasts during human fetal bone development","volume":"208","author":"Johansson","year":"1997","journal-title":"Dev Dyn"},{"key":"10.1016\/j.bone.2011.06.008_bb0120","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0045-6039(87)90479-9","article-title":"Impaired recruitment and differentiation of osteoclast progenitors by osteocalcin-deplete bone implants","volume":"21","author":"Glowacki","year":"1987","journal-title":"Cell Differ"},{"key":"10.1016\/j.bone.2011.06.008_bb0125","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1083\/jcb.200409077","article-title":"Ameloblastin is a cell adhesion molecule required for maintaining the differentiation state of ameloblasts","volume":"167","author":"Fukumoto","year":"2004","journal-title":"J Cell Biol"},{"key":"10.1016\/j.bone.2011.06.008_bb0130","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1600-0722.2006.00403.x","article-title":"Ameloblastin expression during craniofacial bone formation in rats","volume":"114","author":"Spahr","year":"2006","journal-title":"Eur J Oral Sci"},{"key":"10.1016\/j.bone.2011.06.008_bb0135","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.bone.2010.09.007","article-title":"Ameloblastin expression and putative autoregulation in mesenchymal cells suggest a role in early bone formation and repair","volume":"48","author":"Tamburstuen","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.bone.2011.06.008_bb0140","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.bbrc.2007.08.099","article-title":"Osteoblast-specific Angiopoietin 1 overexpression increases bone mass","volume":"362","author":"Suzuki","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bone.2011.06.008_bb0145","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1242\/jcs.040113","article-title":"Claudin-10 exists in six alternatively spliced isoforms that exhibit distinct localization and function","volume":"122","author":"Gunzel","year":"2009","journal-title":"J Cell Sci"},{"key":"10.1016\/j.bone.2011.06.008_bb0150","doi-asserted-by":"crossref","first-page":"22144","DOI":"10.1074\/jbc.M300744200","article-title":"The inhibition of calcium phosphate precipitation by fetuin is accompanied by the formation of a fetuin-mineral complex","volume":"278","author":"Price","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2011.06.008_bb0155","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1042\/bj20030676","article-title":"Tissue distribution and activity testing suggest a similar but not identical function of fetuin-B and fetuin-A","volume":"376","author":"Denecke","year":"2003","journal-title":"Biochem J"},{"key":"10.1016\/j.bone.2011.06.008_bb0160","doi-asserted-by":"crossref","first-page":"19991","DOI":"10.1074\/jbc.M112234200","article-title":"alpha 2-HS glycoprotein\/fetuin, a transforming growth factor-beta\/bone morphogenetic protein antagonist, regulates postnatal bone growth and remodeling","volume":"277","author":"Szweras","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2011.06.008_bb0165","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1083\/jcb.200408013","article-title":"The high mobility group transcription factor Sox8 is a negative regulator of osteoblast differentiation","volume":"168","author":"Schmidt","year":"2005","journal-title":"J Cell Biol"},{"key":"10.1016\/j.bone.2011.06.008_bb0170","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1002\/dvdy.21187","article-title":"Runx2 determines bone maturity and turnover rate in postnatal bone development and is involved in bone loss in estrogen deficiency","volume":"236","author":"Maruyama","year":"2007","journal-title":"Dev Dyn"},{"key":"10.1016\/j.bone.2011.06.008_bb0175","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/jcb.20389","article-title":"Over-expression of fibroblast growth factor-2 causes defective bone mineralization and osteopenia in transgenic mice","volume":"95","author":"Sobue","year":"2005","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.bone.2011.06.008_bb0180","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1172\/JCI8641","article-title":"Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation","volume":"105","author":"Montero","year":"2000","journal-title":"J Clin Invest"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328211010490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328211010490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T23:22:06Z","timestamp":1543706526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328211010490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S8756328211010490"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2011.06.008","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}